Revolution Medicines, Inc. RVMD
867 filings, 9 in the last 30 days
SEC filing indexWhat the 8-Ks said
None of the officer, auditor, restatement, cyber, restructuring, listing, impairment or debt 8-Ks in the last 3 years
From the SEC filing index and the text of each 8-K. A line appears only when the 8-K names one of these items; for item 5.02 only a move of the CEO, CFO, COO or chief accounting officer. Older 8-Ks may have no text downloaded, so they show no quote.
Late filings, 8-K notices and going concern
None found in the last 2 years
-
Late filing notices (NT 10-K, NT 10-Q)No notice in the last 2 years.
-
8-K notices: listing, impairment, debt triggerNo item 3.01, 2.06 or 2.04 in the last 2 years.
-
Going-concern language in the 10-KNo statement of substantial doubt in the latest 10-K.
Facts to read in the filing, not a verdict: many companies with one of these carry on normally, and a company with neither can still have problems.
Every filing on one line
Each mark is a filing or an event in one; the bigger square is a 10-K. Hover for what it is, click to open it.
All 114 events
- Nov 12, 2026 Planned sale JACK LEE ANDERS (Officer) gave notice of a planned sale of 35,750 shares worth about $6.9MForm 144, approximate sale date Nov 11, 2026, under a 10b5-1 plan adopted Aug 12, 2026
- Nov 4, 2026 Planned sale Elizabeth Anderson (a member of our board of directors) adopted a 10b5-1 trading planreported in the 10-Q, up to 25,090 shares, runs to Jun 25, 2027
- Nov 4, 2026 Planned sale Jack Anders (Chief Financial Officer) adopted a 10b5-1 trading planreported in the 10-Q, up to 71,500 shares, runs to Aug 15, 2027
- Nov 4, 2026 Planned sale Steve Kelsey, M.D (President, Research and Development) adopted a 10b5-1 trading planreported in the 10-Q, up to 135,800 shares, runs to May 31, 2027
- Nov 4, 2026 Planned sale Flavia Borellini (a member of our board of directors) adopted a 10b5-1 trading planreported in the 10-Q, up to 14,624 shares, runs to Nov 17, 2027
- Nov 4, 2026 Planned sale Margaret Horn, J.D (Chief Operating Officer) adopted a 10b5-1 trading planreported in the 10-Q, up to 96,775 shares, runs to Aug 10, 2027
- Nov 4, 2026 8-K Quarterly results8-K item 2.02
- Nov 4, 2026 10-Q Quarterly report (10-Q)period ended Sep 30, 2026
- Oct 13, 2026 8-K New debt or obligation, Other events8-K items 2.03, 8.01
- Sep 29, 2026 Planned sale ALAN SANDLER (Officer) gave notice of a planned sale of 6,309 shares worth about $1.3MForm 144, approximate sale date Sep 29, 2026, under a 10b5-1 plan adopted Jun 30, 2026
- Sep 25, 2026 Planned sale ANTHONY MANCINI (Officer) gave notice of a planned sale of 9,363 shares worth about $1.9MForm 144, approximate sale date Sep 25, 2026, under a 10b5-1 plan adopted Jun 11, 2026
- Sep 24, 2026 Planned sale ANTHONY MANCINI (Officer) gave notice of a planned sale of 587 shares worth about $112KForm 144, approximate sale date Sep 24, 2026, under a 10b5-1 plan adopted Jun 11, 2026
- Sep 22, 2026 Planned sale Elizabeth Anderson (Director) gave notice of a planned sale of 15,080 shares worth about $2.9MForm 144, approximate sale date Sep 22, 2026, under a 10b5-1 plan adopted Jun 23, 2026
- Sep 18, 2026 Planned sale ANTHONY MANCINI (Officer) gave notice of a planned sale of 1,764 shares worth about $347KForm 144, approximate sale date Sep 18, 2026, under a 10b5-1 plan adopted Jun 11, 2026
- Sep 15, 2026 Planned sale Anders Jack (Officer) gave notice of a planned sale of 3,939 shares worth about $803KForm 144, approximate sale date Sep 15, 2026, under a 10b5-1 plan adopted May 31, 2023
- Sep 15, 2026 Planned sale Cislini Jeff (Officer) gave notice of a planned sale of 3,272 shares worth about $667KForm 144, approximate sale date Sep 15, 2026, under a 10b5-1 plan adopted May 31, 2023
- Sep 15, 2026 Planned sale Goldsmith Mark A (Officer, Director) gave notice of a planned sale of 13,603 shares worth about $2.8MForm 144, approximate sale date Sep 15, 2026, under a 10b5-1 plan adopted May 31, 2023
- Sep 15, 2026 Planned sale Horn Margaret A (Officer) gave notice of a planned sale of 4,830 shares worth about $984KForm 144, approximate sale date Sep 15, 2026, under a 10b5-1 plan adopted May 31, 2023
- Sep 15, 2026 Planned sale Kelsey Stephen Michael (Officer) gave notice of a planned sale of 5,415 shares worth about $1.1MForm 144, approximate sale date Sep 15, 2026, under a 10b5-1 plan adopted May 31, 2023
- Sep 15, 2026 Planned sale Mancini Anthony (Officer) gave notice of a planned sale of 2,377 shares worth about $484KForm 144, approximate sale date Sep 15, 2026
- Sep 15, 2026 Planned sale Sandler Alan B (Officer) gave notice of a planned sale of 331 shares worth about $67KForm 144, approximate sale date Sep 15, 2026
- Sep 11, 2026 Planned sale STEPHEN KELSEY (Officer) gave notice of a planned sale of 92,531 shares worth about $18.8MForm 144, approximate sale date Sep 11, 2026, under a 10b5-1 plan adopted Jun 12, 2026
- Sep 10, 2026 Planned sale ANTHONY MANCINI (Officer) gave notice of a planned sale of 15,448 shares worth about $3.2MForm 144, approximate sale date Sep 10, 2026, under a 10b5-1 plan adopted Jun 11, 2026
- Sep 1, 2026 8-K Material agreement signed, New debt or obligation8-K items 1.01, 2.03
- Aug 31, 2026 Planned sale Lorence H Kim (Affiliate) gave notice of a planned sale of 73,090 shares worth about $15.2MForm 144, approximate sale date Aug 31, 2026, under a 10b5-1 plan adopted Jun 1, 2026
- Aug 26, 2026 8-K Other events8-K item 8.01
- Aug 21, 2026 Planned sale JEFFREY TODD CISLINI (Officer) gave notice of a planned sale of 75,894 shares worth about $16.1MForm 144, approximate sale date Aug 21, 2026, under a 10b5-1 plan adopted May 22, 2026
- Aug 21, 2026 Planned sale MARK A GOLDSMITH (Director, Officer) gave notice of a planned sale of 80,000 shares worth about $16.9MForm 144, approximate sale date Aug 21, 2026, under a 10b5-1 plan adopted May 22, 2026
- Aug 21, 2026 Planned sale THE REBECCA GOLDSMITH REVOCABLE TRUST (Director, Officer) gave notice of a planned sale of 3,000 shares worth about $635KForm 144, approximate sale date Aug 21, 2026, under a 10b5-1 plan adopted May 22, 2026
- Aug 21, 2026 Planned sale THE JONATHAN GOLDSMITH REVOCABLE TRUST (Director, Officer) gave notice of a planned sale of 3,000 shares worth about $635KForm 144, approximate sale date Aug 21, 2026, under a 10b5-1 plan adopted May 22, 2026
- Aug 5, 2026 Planned sale Jeff Cislini (Senior Vice President, General Counsel and Secretary) adopted a 10b5-1 trading planreported in the 10-Q, up to 21,000 shares, runs to Apr 30, 2027
- Aug 5, 2026 Planned sale Mark A. Goldsmith (President and Chief Executive Officer and Chair of the Board of Directors) adopted a 10b5-1 trading planreported in the 10-Q, up to 12,000 shares, runs to Sep 30, 2027
- Aug 5, 2026 Planned sale Steve Kelsey, M.D (President, Research and Development) adopted a 10b5-1 trading planreported in the 10-Q, up to 92,531 shares, runs to Mar 31, 2027
- Aug 5, 2026 Planned sale Alan Sandler, M.D (Chief Development Officer) adopted a 10b5-1 trading planreported in the 10-Q
- Aug 5, 2026 Planned sale Anthony Mancini, (Chief Global Commercialization Officer) adopted a 10b5-1 trading planreported in the 10-Q, up to 18,950 shares, runs to Mar 3, 2027
- Aug 5, 2026 8-K Quarterly results8-K item 2.02
- Aug 5, 2026 10-Q Quarterly report (10-Q)period ended Jun 30, 2026
- Jun 29, 2026 Planned sale SUSHIL PATEL (Director) gave notice of a planned sale of 5,580 shares worth about $1.0MForm 144, approximate sale date Jun 29, 2026, under a 10b5-1 plan adopted Mar 30, 2026
- Jun 24, 2026 Planned sale JACK ANDERS (Officer) gave notice of a planned sale of 20,000 shares worth about $3.4MForm 144, approximate sale date Jun 24, 2026, under a 10b5-1 plan adopted Mar 24, 2026
- Jun 22, 2026 8-K Director or officer change, Shareholder vote results8-K items 5.02, 5.07
- Jun 15, 2026 Planned sale MARGARET A HORN (Officer) gave notice of a planned sale of 90,000 shares worth about $13.8MForm 144, approximate sale date Jun 15, 2026, under a 10b5-1 plan adopted Mar 12, 2026
- Jun 15, 2026 Planned sale Horn Margaret A (Officer) gave notice of a planned sale of 3,486 shares worth about $536KForm 144, approximate sale date Jun 15, 2026, under a 10b5-1 plan adopted May 31, 2023
- Jun 15, 2026 Planned sale Kelsey Stephen Michael (Officer) gave notice of a planned sale of 4,071 shares worth about $626KForm 144, approximate sale date Jun 15, 2026, under a 10b5-1 plan adopted May 31, 2023
- Jun 15, 2026 Planned sale Mancini Anthony (Officer) gave notice of a planned sale of 4,211 shares worth about $648KForm 144, approximate sale date Jun 15, 2026
- Jun 15, 2026 Planned sale Anders Jack (Officer) gave notice of a planned sale of 2,653 shares worth about $408KForm 144, approximate sale date Jun 15, 2026, under a 10b5-1 plan adopted May 31, 2023
- Jun 15, 2026 Planned sale Cislini Jeff (Officer) gave notice of a planned sale of 1,656 shares worth about $255KForm 144, approximate sale date Jun 15, 2026, under a 10b5-1 plan adopted May 31, 2023
- Jun 15, 2026 Planned sale GOLDSMITH MARK A (Officer, Director) gave notice of a planned sale of 9,772 shares worth about $1.5MForm 144, approximate sale date Jun 15, 2026, under a 10b5-1 plan adopted May 31, 2023
- Jun 11, 2026 Planned sale MARGARET A HORN (Officer) gave notice of a planned sale of 10,000 shares worth about $1.4MForm 144, approximate sale date Jun 11, 2026, under a 10b5-1 plan adopted Mar 12, 2026
- May 26, 2026 Planned sale ANTHONY MANCINI (Officer) gave notice of a planned sale of 3,121 shares worth about $473KForm 144, approximate sale date May 26, 2026, under a 10b5-1 plan adopted Dec 24, 2025
- May 6, 2026 Planned sale Margaret Horn (Chief Operating Officer) adopted a 10b5-1 trading planreported in the 10-Q, up to 100,000 shares, runs to May 31, 2027
- May 6, 2026 Planned sale Jack Anders (Chief Financial Officer) adopted a 10b5-1 trading planreported in the 10-Q, up to 20,000 shares, runs to Jun 15, 2027
- May 6, 2026 Planned sale Sushil Patel (a member of our board of directors) adopted a 10b5-1 trading planreported in the 10-Q, up to 5,580 shares, runs to Mar 30, 2027
- May 6, 2026 8-K Quarterly results8-K item 2.02
- May 6, 2026 10-Q Quarterly report (10-Q)period ended Mar 31, 2026
- Apr 27, 2026 Planned sale ANTHONY MANCINI (Officer) gave notice of a planned sale of 3,120 shares worth about $422KForm 144, approximate sale date Apr 27, 2026, under a 10b5-1 plan adopted Dec 24, 2025
- Apr 17, 2026 8-K Material agreement signed, New debt or obligation, Other events8-K items 1.01, 2.03, 8.01
- Apr 16, 2026 8-K Other events8-K item 8.01
- Apr 15, 2026 Planned sale MARK A GOLDSMITH (Director, Officer) gave notice of a planned sale of 120,000 shares worth about $17.6MForm 144, approximate sale date Apr 15, 2026, under a 10b5-1 plan adopted Nov 25, 2025
- Apr 15, 2026 Offering Sale of 10.6M new shares424B5 · Revolution Medicines, Inc. is offering shares 10,563,381 of its common stock.
- Apr 15, 2026 Offering Convertible notes: $500M424B5 · We are offering $500,000,000 aggregate principal amount of our 0.50% convertible senior notes due 2033.
- Apr 13, 2026 8-K Other events8-K item 8.01
- Mar 26, 2026 Planned sale Mancini Anthony (Officer) gave notice of a planned sale of 37,450 shares worth about $3.6MForm 144, approximate sale date Mar 25, 2026, under a 10b5-1 plan adopted Dec 24, 2025
- Mar 19, 2026 Planned sale JEFFREY TODD CISLINI (Officer) gave notice of a planned sale of 1,163 shares worth about $114KForm 144, approximate sale date Mar 19, 2026, under a 10b5-1 plan adopted Mar 13, 2025
- Mar 13, 2026 Planned sale Anders Jack (Officer) gave notice of a planned sale of 2,134 shares worth about $213KForm 144, approximate sale date Mar 16, 2026, under a 10b5-1 plan adopted May 31, 2023
- Mar 13, 2026 Planned sale Cislini Jeff (Officer) gave notice of a planned sale of 2,053 shares worth about $204KForm 144, approximate sale date Mar 16, 2026, under a 10b5-1 plan adopted May 31, 2023
- Mar 13, 2026 Planned sale GOLDSMITH MARK A (Officer, Director) gave notice of a planned sale of 13,261 shares worth about $1.3MForm 144, approximate sale date Mar 16, 2026, under a 10b5-1 plan adopted May 31, 2023
- Mar 13, 2026 Planned sale Horn Margaret A (Officer) gave notice of a planned sale of 4,722 shares worth about $470KForm 144, approximate sale date Mar 16, 2026, under a 10b5-1 plan adopted May 31, 2023
- Mar 13, 2026 Planned sale Kelsey Stephen Michael (Officer) gave notice of a planned sale of 3,901 shares worth about $389KForm 144, approximate sale date Mar 16, 2026, under a 10b5-1 plan adopted May 31, 2023
- Mar 13, 2026 Planned sale Wei Lin (Officer) gave notice of a planned sale of 2,288 shares worth about $228KForm 144, approximate sale date Mar 16, 2026, under a 10b5-1 plan adopted Dec 23, 2024
- Mar 13, 2026 Planned sale Wang Xiaolin (Officer) gave notice of a planned sale of 2,282 shares worth about $227KForm 144, approximate sale date Mar 16, 2026, under a 10b5-1 plan adopted Nov 17, 2025
- Mar 2, 2026 Planned sale MARK A GOLDSMITH (Director, Officer) gave notice of a planned sale of 30,000 shares worth about $3.1MForm 144, approximate sale date Mar 2, 2026, under a 10b5-1 plan adopted Nov 25, 2025
- Mar 2, 2026 Planned sale THE REBECCA GOLDSMITH REVOCABLE TRUST (Director, Officer) gave notice of a planned sale of 3,000 shares worth about $306KForm 144, approximate sale date Mar 2, 2026, under a 10b5-1 plan adopted Nov 25, 2025
- Mar 2, 2026 Planned sale JONATHAN GOLDSMITH REVOCABLE TRUST (Director, Officer) gave notice of a planned sale of 3,000 shares worth about $306KForm 144, approximate sale date Mar 2, 2026, under a 10b5-1 plan adopted Nov 25, 2025
- Feb 25, 2026 Planned sale Mark A. Goldsmith (M.D., Ph.D., our President and Chief Executive Officer and Chair of the Board of Directors) adopted a 10b5-1 trading planreported in the 10-K, up to 150,000 shares, runs to Mar 31, 2027
- Feb 25, 2026 Planned sale Wei Lin (M.D., our Chief Medical Officer) adopted a 10b5-1 trading planreported in the 10-K
- Feb 25, 2026 Offering At-the-market program: up to $1.0B of common stock424B5 · In accordance with the terms of the sales agreement, we may offer and sell shares of our common stock, $0.0001 par value per share, having an aggregate offering price of up to $1.0 billion from time to time through or to TD Cowen acting as our agent or principal.
- Feb 25, 2026 8-K Quarterly results8-K item 2.02
- Feb 25, 2026 10-K Annual report (10-K)period ended Dec 31, 2025
- Jan 21, 2026 Planned sale JEFFREY TODD CISLINI (Officer) gave notice of a planned sale of 908 shares worth about $106KForm 144, approximate sale date Jan 21, 2026, under a 10b5-1 plan adopted Mar 13, 2025
- Jan 7, 2026 Planned sale JACK LEE ANDERS (Officer) gave notice of a planned sale of 10,000 shares worth about $798KForm 144, approximate sale date Jan 7, 2026, under a 10b5-1 plan adopted Dec 16, 2024
- Jan 7, 2026 Planned sale MARGARET A HORN (Officer) gave notice of a planned sale of 75,000 shares worth about $6.0MForm 144, approximate sale date Jan 7, 2026, under a 10b5-1 plan adopted Mar 7, 2025
- Dec 12, 2025 Planned sale Horn Margaret A (Officer) gave notice of a planned sale of 4,711 shares worth about $367KForm 144, approximate sale date Dec 15, 2025, under a 10b5-1 plan adopted May 31, 2023
- Dec 12, 2025 Planned sale Anders Jack (Officer) gave notice of a planned sale of 3,017 shares worth about $235KForm 144, approximate sale date Dec 15, 2025, under a 10b5-1 plan adopted May 31, 2023
- Dec 12, 2025 Planned sale Cislini Jeff (Officer) gave notice of a planned sale of 2,614 shares worth about $203KForm 144, approximate sale date Dec 15, 2025, under a 10b5-1 plan adopted May 31, 2023
- Dec 12, 2025 Planned sale Kelsey Stephen Michael (Officer) gave notice of a planned sale of 5,296 shares worth about $412KForm 144, approximate sale date Dec 15, 2025, under a 10b5-1 plan adopted May 31, 2023
- Dec 12, 2025 Planned sale GOLDSMITH MARK A (Officer, Director) gave notice of a planned sale of 14,964 shares worth about $1.2MForm 144, approximate sale date Dec 15, 2025, under a 10b5-1 plan adopted May 31, 2023
- Nov 25, 2025 Planned sale JACK LEE ANDERS (Officer) gave notice of a planned sale of 5,418 shares worth about $399KForm 144, approximate sale date Nov 25, 2025, under a 10b5-1 plan adopted Dec 16, 2024
- Nov 25, 2025 Planned sale MARK A GOLDSMITH (Director, Officer) gave notice of a planned sale of 60,000 shares worth about $4.4MForm 144, approximate sale date Nov 25, 2025, under a 10b5-1 plan adopted Dec 19, 2024
- Nov 25, 2025 Planned sale THE REBECCA GOLDSMITH REVOCABLE TRUST (Director, Officer) gave notice of a planned sale of 3,000 shares worth about $221KForm 144, approximate sale date Nov 25, 2025, under a 10b5-1 plan adopted Dec 19, 2024
- Nov 25, 2025 Planned sale J H GOLDSMITH & M A GOLDSMITHCO-TTEE JONATHAN GOLDSMITH REV TRU/A/D 8/16/2023 (Director, Officer) gave notice of a planned sale of 3,000 shares worth about $221KForm 144, approximate sale date Nov 25, 2025, under a 10b5-1 plan adopted Dec 19, 2024
- Nov 18, 2025 Planned sale JEFFREY TODD CISLINI (Officer) gave notice of a planned sale of 13,388 shares worth about $926KForm 144, approximate sale date Nov 18, 2025, under a 10b5-1 plan adopted Mar 13, 2025
- Nov 18, 2025 Planned sale MARK A GOLDSMITH (Director, Officer) gave notice of a planned sale of 20,000 shares worth about $1.4MForm 144, approximate sale date Nov 18, 2025, under a 10b5-1 plan adopted Dec 19, 2024
- Nov 5, 2025 8-K Quarterly results8-K item 2.02
- Nov 5, 2025 10-Q Quarterly report (10-Q)period ended Sep 30, 2025
- Oct 17, 2025 8-K Other events8-K item 8.01
- Sep 10, 2025 8-K Other events8-K item 8.01
- Aug 6, 2025 8-K Quarterly results8-K item 2.02
- Aug 6, 2025 10-Q Quarterly report (10-Q)period ended Jun 30, 2025
- Jun 27, 2025 8-K Shareholder vote results8-K item 5.07
- Jun 24, 2025 8-K Material agreement signed, New debt or obligation, Regulation FD disclosure8-K items 1.01, 2.03, 7.01
- Jun 18, 2025 8-K Director or officer change8-K item 5.02
- May 7, 2025 Planned sale Steve Kelsey (M.D., FRCP, FRCPath, President, Research and Development) adopted a 10b5-1 trading planreported in the 10-Q, up to 150,000 shares, runs to Oct 31, 2025
- May 7, 2025 Planned sale Margaret Horn (Chief Operating Officer) adopted a 10b5-1 trading planreported in the 10-Q, up to 75,000 shares, runs to Jun 6, 2026
- May 7, 2025 Planned sale Jeff Cislini (Senior Vice President, General Counsel and Secretary) adopted a 10b5-1 trading planreported in the 10-Q, up to 17,388 shares, runs to Jun 15, 2026
- May 7, 2025 8-K Quarterly results8-K item 2.02
- May 7, 2025 10-Q Quarterly report (10-Q)period ended Mar 31, 2025
- Feb 26, 2025 Planned sale Jack Anders (Chief Financial Officer) adopted a 10b5-1 trading planreported in the 10-K, up to 35,418 shares, runs to Mar 13, 2026
- Feb 26, 2025 Planned sale Mark A. Goldsmith (M.D., Ph.D., our President and Chief Executive Officer and Chair of the Board of Directors) adopted a 10b5-1 trading planreported in the 10-K, up to 150,000 shares, runs to Mar 31, 2026
- Feb 26, 2025 Planned sale Wei Lin (M.D., our Chief Medical Officer) adopted a 10b5-1 trading planreported in the 10-K
- Feb 26, 2025 8-K Quarterly results8-K item 2.02
- Feb 26, 2025 10-K Annual report (10-K)period ended Dec 31, 2024
- Dec 5, 2024 Offering Sale of 14.1M new shares424B5 · Common Stock Revolution Medicines, Inc. is offering 14,130,436 shares of its common stock and, in lieu of offering shares of its common stock to certain investors, pre-funded warrants to purchase 2,173,917 shares of its common stock.
- Dec 5, 2024 8-K Other events8-K item 8.01
- Dec 2, 2024 8-K Other events8-K item 8.01
From the SEC filing index. Insider purchases go back 180 days (the Form 4s downloaded).
Every filing
Newest first, by kind · each form links to sec.gov
| Filed | Form | What it is |
|---|---|---|
| Nov 13, 2026 | 4 | Insider trade |
| Nov 13, 2026 | 4 | Insider trade |
| Nov 12, 2026 | 144 | Notice of planned insider sale |
| Nov 12, 2026 | 4 | Insider trade |
| Nov 5, 2026 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Nov 4, 2026 | 10-Q | Quarterly report |
| Nov 4, 2026 | 8-K | Quarterly results |
| Oct 30, 2026 | SCHEDULE 13G | 5%+ owner (passive) |
| Oct 28, 2026 | 4 | Insider trade |
| Oct 13, 2026 | 8-K | New debt or obligation, Other events |
| Oct 1, 2026 | 4 | Insider trade |
| Sep 29, 2026 | 4 | Insider trade |
| Sep 29, 2026 | 144 | Notice of planned insider sale |
| Sep 28, 2026 | 4 | Insider trade |
| Sep 25, 2026 | 144 | Notice of planned insider sale |
| Sep 24, 2026 | 144 | Notice of planned insider sale |
| Sep 24, 2026 | 4 | Insider trade |
| Sep 22, 2026 | 4 | Insider trade |
| Sep 22, 2026 | 144 | Notice of planned insider sale |
| Sep 18, 2026 | 4 | Insider trade |
| Sep 18, 2026 | 4 | Insider trade |
| Sep 18, 2026 | 144 | Notice of planned insider sale |
| Sep 18, 2026 | 4 | Insider trade |
| Sep 18, 2026 | 4 | Insider trade |
| Sep 18, 2026 | 4 | Insider trade |
| Sep 18, 2026 | 4 | Insider trade |
| Sep 18, 2026 | 4 | Insider trade |
| Sep 15, 2026 | 144 | Notice of planned insider sale |
| Sep 15, 2026 | 144 | Notice of planned insider sale |
| Sep 15, 2026 | 144 | Notice of planned insider sale |
| Sep 15, 2026 | 144 | Notice of planned insider sale |
| Sep 15, 2026 | 144 | Notice of planned insider sale |
| Sep 15, 2026 | 4 | Insider trade |
| Sep 15, 2026 | 144 | Notice of planned insider sale |
| Sep 15, 2026 | 144 | Notice of planned insider sale |
| Sep 14, 2026 | 4 | Insider trade |
| Sep 11, 2026 | 144 | Notice of planned insider sale |
| Sep 10, 2026 | 144 | Notice of planned insider sale |
| Sep 10, 2026 | 4 | Insider trade |
| Sep 2, 2026 | 4 | Insider trade |
| Sep 1, 2026 | 8-K | Material agreement signed, New debt or obligation |
| Aug 31, 2026 | 144 | Notice of planned insider sale |
| Aug 26, 2026 | 8-K | Other events |
| Aug 25, 2026 | 4 | Insider trade |
| Aug 25, 2026 | 4 | Insider trade |
| Aug 21, 2026 | 144 | Notice of planned insider sale |
| Aug 21, 2026 | 144 | Notice of planned insider sale |
| Aug 21, 2026 | 144 | Notice of planned insider sale |
| Aug 21, 2026 | 144 | Notice of planned insider sale |
| Aug 14, 2026 | SCHEDULE 13G | 5%+ owner (passive) |
| Aug 13, 2026 | SCHEDULE 13G | 5%+ owner (passive) |
| Aug 13, 2026 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Aug 5, 2026 | 10-Q | Quarterly report |
| Aug 5, 2026 | 8-K | Quarterly results |
| Jul 29, 2026 | SCHEDULE 13G | 5%+ owner (passive) |
| Jul 1, 2026 | 4 | Insider trade |
| Jun 29, 2026 | 144 | Notice of planned insider sale |
| Jun 26, 2026 | 4 | Insider trade |
| Jun 24, 2026 | 144 | Notice of planned insider sale |
| Jun 23, 2026 | 4 | Insider trade |
| Jun 23, 2026 | 4 | Insider trade |
| Jun 23, 2026 | 4 | Insider trade |
| Jun 23, 2026 | 4 | Insider trade |
| Jun 23, 2026 | 4 | Insider trade |
| Jun 23, 2026 | 4 | Insider trade |
| Jun 23, 2026 | 4 | Insider trade |
| Jun 22, 2026 | 8-K | Director or officer change, Shareholder vote results |
| Jun 18, 2026 | 4 | Insider trade |
| Jun 18, 2026 | 4 | Insider trade |
| Jun 18, 2026 | 4 | Insider trade |
| Jun 18, 2026 | 4 | Insider trade |
| Jun 18, 2026 | 4 | Insider trade |
| Jun 17, 2026 | 4 | Insider trade |
| Jun 15, 2026 | 144 | Notice of planned insider sale |
| Jun 15, 2026 | 144 | Notice of planned insider sale |
| Jun 15, 2026 | 144 | Notice of planned insider sale |
| Jun 15, 2026 | 144 | Notice of planned insider sale |
| Jun 15, 2026 | 4 | Insider trade |
| Jun 15, 2026 | 144 | Notice of planned insider sale |
| Jun 15, 2026 | 144 | Notice of planned insider sale |
| Jun 15, 2026 | 144 | Notice of planned insider sale |
| Jun 11, 2026 | 144 | Notice of planned insider sale |
| May 28, 2026 | 4 | Insider trade |
| May 26, 2026 | 144 | Notice of planned insider sale |
| May 15, 2026 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| May 6, 2026 | 10-Q | Quarterly report |
| May 6, 2026 | 8-K | Quarterly results |
| Apr 29, 2026 | 4 | Insider trade |
| Apr 28, 2026 | DEFA14A | Extra proxy material |
| Apr 28, 2026 | ARS | Annual report to shareholders |
| Apr 27, 2026 | 144 | Notice of planned insider sale |
| Apr 27, 2026 | DEF 14A | Proxy statement |
| Apr 17, 2026 | 4 | Insider trade |
| Apr 17, 2026 | 8-K | Material agreement signed, New debt or obligation, Other events |
| Apr 16, 2026 | 8-K | Other events |
| Apr 15, 2026 | 144 | Notice of planned insider sale |
| Apr 15, 2026 | 424B5 | Prospectus |
| Apr 15, 2026 | 424B5 | Prospectus |
| Apr 15, 2026 | 305B2 | |
| Apr 15, 2026 | FWP | Offering terms |
Show the other 75 filings on this page
Press releases with quarterly results are attached to the 8-Ks marked "Quarterly results"; read them on Earnings releases.
Sources
SEC's filing index (data.sec.gov submissions). Each form links to the document on sec.gov.
Also
Earnings releases: the text of each quarter's results release. Statements by period: the income statement, balance sheet or cash flow of the last filings side by side.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/RVMD/export.csv") into a cell.